Europe Intra-Articular Injection for Osteoarticular Infiltrations Market
The Europe Intra-Articular Injection for Osteoarticular Infiltrations Market size was valued at US$ 97.43 Mn in 2023 and is projected to reach US$ 157.08 Mn by 2031, growing at a CAGR of 6.2% during 2023 - 2031.
Report Coverage
- Type: Type 1 Collagen, Hyaluronic Acid
- End User: Hospitals, Orthopedic Clinics
US$ 97.43 Mn
Market size in 2023
US$ 157.08 Mn
Market Size by 2031
6.2%
CAGR, 2023 - 2031
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Intra-Articular Injection for Osteoarticular Infiltrations Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Country Analysis
6.2 Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Revenue 2021-2031 (US$ Million)
6.3 Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Forecast Analysis
7. Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Analysis – by Type
7.1 Type 1 Collagen
- 7.1.1 Overview
- 7.1.2 Type 1 Collagen: Europe Intra-Articular Injection for Osteoarticular Infiltrations Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Hyaluronic Acid
- 7.2.1 Overview
- 7.2.2 Hyaluronic Acid: Europe Intra-Articular Injection for Osteoarticular Infiltrations Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Europe Intra-Articular Injection for Osteoarticular Infiltrations Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Orthopedic Clinics
- 8.2.1 Overview
- 8.2.2 Orthopedic Clinics: Europe Intra-Articular Injection for Osteoarticular Infiltrations Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Europe Intra-Articular Injection for Osteoarticular Infiltrations Market – Europe (UK, Germany, France, Russia, Italy, Rest of Europe) Analysis
9.1 Europe (UK, Germany, France, Russia, Italy, Rest of Europe)
- 9.1.1 Europe (UK, Germany, France, Russia, Italy, Rest of Europe): Europe Intra-Articular Injection for Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
- 9.1.1.1 Europe (UK, Germany, France, Russia, Italy, Rest of Europe): Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Breakdown, by Type
- 9.1.1.2 Europe (UK, Germany, France, Russia, Italy, Rest of Europe): Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Bioventus Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 SEIKAGAKU CORPORATION
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Maxigen Biotech Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 stem Medical Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Sanofi SA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Ferring Pharmaceuticals
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Fidia Pharma USA Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Biotech Healthcare Group
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Bioteck S.p.A.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 I+MED.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.